UPLOAD Filing
Edesa Biotech, Inc.
Date: July 30, 2025 · CIK: 0001540159 · Accession: 0000000000-25-008033
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-288966
Letter
Re: Edesa Biotech, Inc. Registration Statement on Form S-3 Filed July 25, 2025 File No. 333-288966 Dear Peter Weiler:
July 30, 2025
Peter Weiler Chief Financial Officer Edesa Biotech, Inc. 100 Spy Court Markham, Ontario, Canada L3R 5H6
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Chris Edwards at 202-551-6761 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Tracy F. Buffer
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> July 30, 2025 Peter Weiler Chief Financial Officer Edesa Biotech, Inc. 100 Spy Court Markham, Ontario, Canada L3R 5H6 Re: Edesa Biotech, Inc. Registration Statement on Form S-3 Filed July 25, 2025 File No. 333-288966 Dear Peter Weiler: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Chris Edwards at 202-551-6761 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Tracy F. Buffer </TEXT> </DOCUMENT>